Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 072
Main content starts here.
The Examiner has the burden of providing specific and sufficient reasons for doubting any assertions in the specification as to the scope of enablement. Unpredictability in the art and lack of working examples are important in questioning whether the invention is enabled throughout the scope of the claim; In re Wright, 999 F.2d 1551, 1562, 27 USPQ2d 1510, 1513 (Fed. Cir. 1993); In re Vaeck, 947 F.2d 488, 495-96, 20 USPQ2d 1438, 1444-45 (Fed. Cir. 1991); In re Goodman, 11 F.3d 1046, 1050, 29 USPQ2d 2010, 2013 (fed. Cir. 1993).
If possible, published documents should be cited to support the Examiner's position.
The Examiner must consider in light of all the evidence whether there is sufficient disclosure to teach those of skill how to make and use the invention as broadly as it is claimed.